APIS ESR1 Mutations Controls

The APIS ESR1 Mutations Controls serve as a quality control material and can be used for oestrogen receptor gene (ESR1) mutations assay validations, or alongside the APIS ESR1 Mutations Kit as run validity controls. The product consists of two tubes, a negative and a positive control. The positive control contains DNA fragments encoding eleven mutations within the ESR1 gene, as well as a reference sequence encoding a fragment of exon 3.

Targets Covered by the APIS ESR1 Mutations Controls

Table 1. 11 ESR1 targets detected in the APIS ESR1 Mutations Controls.

APIS ESR1 Mutations Controls Recommended Workflow

Figure 1. Recommended workflow for the APIS ESR1 Mutations Controls.

APIS ESR1 Mutations Kit and Controls

The APIS ESR1 Mutations Controls can be used in combination with the APIS ESR1 Mutations Kit for the detection of 11 ESR1 mutations from DNA (e.g. cfDNA) using qPCR assay. The controls allow users to expand sample testing across more PCR plates.

APIS ESR1 Mutations Controls

The APIS ESR1 Mutations Controls is currently available as a research use only (RUO) product. Not applicable for use in diagnostic procedures.

For more information on this product please contact us and select ‘ESR1 Mutations Controls’

Ordering Information

ProductTest TypeKit SizeCatalogue NumberPrice
APIS ESR1 Mutations KitRUO24 samples plus controls 02201 (distributed by APIS)Available upon request
APIS ESR1 Mutations KitRUO24 samples plus controls02202 (distributed by Biocartis)Available upon request
APIS ESR1 Mutations ControlsRUO24 reactions02801 (distributed by APIS)Available upon request
APIS ESR1 Mutations ControlsRUO24 reactions02802 (distributed by Biocartis)Available upon request

Biocartis distributes directly to the following countries: Austria, Belgium, Denmark, France, Germany, Greece, Hungary, Italy, Liechtenstein, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of Cyprus, Republic of Ireland, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States of America.

Biocartis distributes via local distributors to the following countries: Australia, Brazil, Bulgaria, Chile, Colombia, Czechia, Croatia, Ecuador, Estonia, Finland, Hong Kong, Israel, Jordan, Latvia, Lebanon, Lithuania, Malaysia, Mexico, New Zealand, Philippines, Qatar, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, Thailand, Turkey, United Arab Emirates

Shiva Scientific is the distributor in India.

APIS is the distributor for all other countries.

To order the APIS ESR1 Mutations Controls or to learn more about how our assay can elevate your breast cancer research capabilities, please contact us by clicking below.